K173523 is an FDA 510(k) clearance for the BD Phoenix Automated Microbiology System - GN Meropenem-vaborbactam (0.125/8-32/8 ug/mL). This device is classified as a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II - Special Controls, product code LON).
Submitted by Becton, Dickinson and Company (Sparks, US). The FDA issued a Cleared decision on February 9, 2018, 87 days after receiving the submission on November 14, 2017.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1645.